NOV 28, 2015 5:37 AM PST

Bat Immune Receptors Are Different Than Other Mammals

WRITTEN BY: Kara Marker
Bats may be able to defend against pathogens differently than other mammals because their immunological first line of defense is totally unique. 

Toll-like receptors (TLRs) are employed by the immune system as first responders to invading pathogens, warning the rest of the lymphocyte army that a foreign particle is present through a mechanism called pattern recognition (Nature). In a recent study published in Molecular Ecology, scientists discovered that bat TLRs perform pattern recognition differently than other mammals, enabling them to recognize pathogens differently, potentially more efficiently. 
A bat TLR - colored regions indicating unique mutations

Scientists believe this unique ability of the bats' non-specific immune response may explain why bat species suffer less from pathogens that severely disable other mammal species. They are also beginning to draw connections from this discovery to the cases where bats serve as resevoirs for disease. Perhaps if bats can detect pathogens early, they can provide enhanced immunity to infection. 

TLRs recognize unique characteristics on pathogens such as "molecular signatures" and nucleic acids. Distinctive mutations can be seen in bat TLRs that affect how they recognize different pathogens. What is it about these genetic changes that helps bats receive unique signals differently than other mammals? Scientists are still looking into the molecular differences.

"The genetic variability of the bat immune system has been little investigated," the team reported. 

In addition to unique TLRs, bats also exhibit other unique traits from other mammals. Their ability to take flight and "exceptional breadth in diet" are linked to their ability to fulfill a wide variety of niches. 

"These niches also have specific pathogen profiles which are likely to have shaped the evolution of bat TLRs in an order-specific manner," theorized lead author Dr. Marina Escalera. 

Watch the video below to see an animation of the molecular characteristics of TLRs.
Source: Forschungsverbund Berlin e.V.
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog:
You May Also Like
AUG 06, 2019
AUG 06, 2019
Lab Mice Born to Moms From the Wild Make Better Research Models
A standard research mouse genotype was preserved while generating a natural microbiome by using wild mice as surrogates....
AUG 13, 2019
Health & Medicine
AUG 13, 2019
Blood-Brain Barrier Impairment and Its Role in Alzheimer's Disease
In healthy people, the blood-brain barrier (BBB), which is fromed by brain endothelial cells, strictly controls the entrance of harmful materials into...
SEP 25, 2019
SEP 25, 2019
Your Immune Response Varies from AM to PM
“My biological clock is ticking.” We’ve heard people say this phrase - maybe even said it ourselves - but what do we mean exactly? Often...
JAN 04, 2020
JAN 04, 2020
Why Do Skincare Products Sometimes Cause Rashes?
Chemicals commonly found in skincare products are intended to avoid interactions with the part of the immune system responsible for triggering allergic inf...
JAN 22, 2020
JAN 22, 2020
How the VISTA molecule affects immune responses
A new study describes how a molecule named VISTA has been impeding immune responses in cancer therapies. By turning this molecule “off,” resear...
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
Potential Cure for Coronavirus Found in Thailand
Doctors in Thailand have successfully treated people affected by the coronavirus via a new drug cocktail made out of antiviral, flu and HIV medication. Alt...
Loading Comments...